Literature DB >> 25315507

Genome modification by CRISPR/Cas9.

Yuanwu Ma1, Lianfeng Zhang, Xingxu Huang.   

Abstract

Clustered regularly interspaced short palindromic repeats (CRISPR)-CRISPR-associated protein (Cas)9-mediated genome modification enables us to edit the genomes of a variety of organisms rapidly and efficiently. The advantages of the CRISPR-Cas9 system have made it an increasingly popular genetic engineering tool for biological and therapeutic applications. Moreover, CRISPR-Cas9 has been employed to recruit functional domains that repress/activate gene expression or label specific genomic loci in living cells or organisms, in order to explore developmental mechanisms, gene expression regulation, and animal behavior. One major concern about this system is its specificity; although CRISPR-Cas9-mediated off-target mutation has been broadly studied, more efforts are required to further improve the specificity of CRISPR-Cas9. We will also discuss the potential applications of CRISPR-Cas9.
© 2014 FEBS.

Keywords:  CRISPR; Cas9; gene targeting; genome editing; sgRNA

Mesh:

Substances:

Year:  2014        PMID: 25315507     DOI: 10.1111/febs.13110

Source DB:  PubMed          Journal:  FEBS J        ISSN: 1742-464X            Impact factor:   5.542


  42 in total

1.  PML plays both inimical and beneficial roles in HSV-1 replication.

Authors:  Pei Xu; Stephen Mallon; Bernard Roizman
Journal:  Proc Natl Acad Sci U S A       Date:  2016-05-09       Impact factor: 11.205

2.  Linking DNA polymerase theta structure and function in health and disease.

Authors:  Kelly Beagan; Mitch McVey
Journal:  Cell Mol Life Sci       Date:  2015-10-29       Impact factor: 9.261

3.  A CRISPRi-dCas9 System for Archaea and Its Use To Examine Gene Function during Nitrogen Fixation by Methanosarcina acetivorans.

Authors:  Ahmed E Dhamad; Daniel J Lessner
Journal:  Appl Environ Microbiol       Date:  2020-10-15       Impact factor: 4.792

4.  A simple method based on Sanger sequencing and MS Word wildcard searching to identify Cas9-induced frameshift mutations.

Authors:  Hui Jie; Zhuoling Li; Ping Wang; Linjie Zhao; Qian Zhang; Xiaomin Yao; Xiangrong Song; Yinglan Zhao; Shaohua Yao
Journal:  Lab Invest       Date:  2017-08-21       Impact factor: 5.662

Review 5.  Chimeric antigen receptor therapy in hematological malignancies: antigenic targets and their clinical research progress.

Authors:  Juanjuan Zhao; Meirong Wu; Zhifeng Li; Sheng Su; Yin Wen; Litian Zhang; Yuhua Li
Journal:  Ann Hematol       Date:  2020-05-09       Impact factor: 3.673

Review 6.  Adeno-Associated Virus (AAV) gene therapy for cystic fibrosis: current barriers and recent developments.

Authors:  William B Guggino; Liudmila Cebotaru
Journal:  Expert Opin Biol Ther       Date:  2017-07-06       Impact factor: 4.388

Review 7.  CRISPR-Cas9: A multifaceted therapeutic strategy for cancer treatment.

Authors:  Itishree Kaushik; Sharavan Ramachandran; Sanjay K Srivastava
Journal:  Semin Cell Dev Biol       Date:  2019-05-04       Impact factor: 7.727

8.  Nutritional Control of Insect Reproduction.

Authors:  Vlastimil Smykal; Alexander S Raikhel
Journal:  Curr Opin Insect Sci       Date:  2015-10-01       Impact factor: 5.186

Review 9.  New approaches to moderate CRISPR-Cas9 activity: Addressing issues of cellular uptake and endosomal escape.

Authors:  Maja van Hees; Sofie Slott; Anders Højgaard Hansen; Heon Seok Kim; Hanlee P Ji; Kira Astakhova
Journal:  Mol Ther       Date:  2021-06-04       Impact factor: 11.454

Review 10.  New Insights into the Therapeutic Applications of CRISPR/Cas9 Genome Editing in Breast Cancer.

Authors:  Munazza Ahmed; Grace Hope Daoud; Asmaa Mohamed; Rania Harati
Journal:  Genes (Basel)       Date:  2021-05-12       Impact factor: 4.096

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.